International Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of Different Doses of Injectable Coenzyme I (NAD+) in the Treatment of Ovarian Function Decline

Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125759) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of Different Doses of Injectable Coenzyme I (NAD+) in the Treatment of Ovarian Function Decline' on May 31.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Third Hospital

Condition: Ovarian Function Decline

Intervention: Experimental group:Participants will receive treatment for two consecutive cycles, with dosing initiated during the follicular phase of each menstrual cycle (Cycle 1 [C1] and Cycle 2 [C2]) (recommended to start 1-2 days after the ...